论文部分内容阅读
目的 观察强肝胶囊对慢性肝炎病人血清肝纤维化指标 (HA、CⅣ、PCⅢ、LN)的影响。方法 治疗组 (n =6 9)给予强肝胶囊 ,每日 3次 ,每次 5片 ,连续 3个月。对照组 (n =5 2 )采用常规护肝降酶等治疗。治疗前、后分别检测血清肝纤维化指标 (HA、CⅣ、PCⅢ、LN)。结果 治疗组血清肝纤维化指标 (HA、CⅣ、PCⅢ、LN)明显下降 ,与对照组比较 ,差异有显著意义 (P <0 0 1)。结论 强肝胶囊有较好的抗肝纤维化作用 ,是治疗肝纤维化的有效药物之一。
Objective To observe the effect of Qianggan Capsule on serum levels of hepatic fibrosis (HA, C Ⅳ, PC Ⅲ, LN) in patients with chronic hepatitis. Methods The treatment group (n = 69) was given Qianggan capsule three times a day for 5 times each for 3 months. The control group (n = 52) was treated with routine protection of liver enzymes and other enzymes. Serum levels of liver fibrosis (HA, CⅣ, PCⅢ, LN) were measured before and after treatment. Results The serum levels of hepatic fibrosis (HA, CⅣ, PCⅢ, LN) in the treatment group were significantly lower than those in the control group (P <0.01). Conclusion QGH has good anti-hepatic fibrosis effect and is one of the effective drugs for treating liver fibrosis.